Reinhard E Friedrich1, Falk WÜsthoff2, Andreas M Luebke3, Felix K Kohlrusch2, Ilse Wieland4, Martin Zenker4, Martin Gosau2. 1. Department of Oral and Maxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany; rfriedrich@uke.de. 2. Department of Oral and Maxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany. 3. Institute of Pathology, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany. 4. Institute of Human Genetics, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Abstract
The aim of this case report was to detail diagnosis and therapy in a case of implant-associated peripheral giant cell granuloma (IA-PGCG) of the jaw. Case Report: The 41-year-old female attended the outpatient clinic for treatment of recurrent mandibular IA-PGCG. The lesion was excised and the defect was closed with a connective tissue graft of the palate. Healing of oral defects was uneventful, and no local recurrence has occurred during a follow-up of 7 months. Genetic examination of the lesion identified a somatic mutation in KRAS. Conclusion: The lesions are assessed as reactive-inflammatory changes in the mucous membrane of the oral cavity. The cause of the lesion is unknown. KRAS mutations are commonly found in various cancer tissues, but also in germline and mosaic RASopathies. Recently, KRAS mutations have been identified in several IA-PGCG. The clinical course of a frequently locally recurring lesion gives rise to the assumption that lesions of this type show characteristics known in benign neoplasms. Copyright
The aim of this case report was to detail diagnosis and therapy in a case of implant-associated peripheral giant cell granuloma (IA-PGCG) of the jaw. Case Report: The 41-year-old female attended the outpatient clinic for treatment of recurrent mandibular IA-PGCG. The lesion was excised and the defect was closed with a connective tissue graft of the palate. Healing of oral defects was uneventful, and no local recurrence has occurred during a follow-up of 7 months. Genetic examination of the lesion identified a somatic mutation in KRAS. Conclusion: The lesions are assessed as reactive-inflammatory changes in the mucous membrane of the oral cavity. The cause of the lesion is unknown. KRAS mutations are commonly found in various cancer tissues, but also in germline and mosaic RASopathies. Recently, KRAS mutations have been identified in several IA-PGCG. The clinical course of a frequently locally recurring lesion gives rise to the assumption that lesions of this type show characteristics known in benign neoplasms. Copyright
Authors: Maria A Peñarrocha-Diago; Juan Cervera-Ballester; Laura Maestre-Ferrín; David Peñarrocha-Oltra Journal: J Oral Implantol Date: 2012-06-19 Impact factor: 1.779
Authors: Carolina C Gomes; Marina G Diniz; Victor C Bastos; Vanessa F Bernardes; Ricardo S Gomez Journal: J Pathol Date: 2019-12-18 Impact factor: 7.996
Authors: Oscar F Chacon-Camacho; Daniel Lopez-Moreno; Martha A Morales-Sanchez; Enriqueta Hofmann; Michelle Pacheco-Quito; Ilse Wieland; Vianney Cortes-Gonzalez; Cristina Villanueva-Mendoza; Martin Zenker; Juan Carlos Zenteno Journal: Mol Genet Genomic Med Date: 2019-03-19 Impact factor: 2.183
Authors: Michal Kovac; Baptiste Ameline; Sebastian Ribi; Monika Kovacova; William Cross; Maxim Barenboim; Olaf Witt; Stefan Bielack; Andreas Krieg; Wolfgang Hartmann; Michaela Nathrath; Daniel Baumhoer Journal: J Pathol Date: 2021-05-25 Impact factor: 7.996